GlobeNewswire

Abiomed to Appoint New Chief Financial Officer Todd A. Trapp

Del

DANVERS, Mass., March 30, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Todd A. Trapp will be appointed as Vice President and Chief Financial Officer, effective April 9, 2018.

Mr. Trapp, 47, joins Abiomed from Watts Water Technologies, Inc., where he served as CFO since 2015. Watts Water Technologies is a $1.5B global manufacturing leader of innovative products to control the efficiency, safety and quality of water within residential and commercial applications. Prior to joining Watts Water Technologies, Mr. Trapp spent 13 years in a variety of financial and operational roles at Honeywell International Inc., a $40B diversified technology and manufacturing company. At Honeywell, Mr. Trapp served as Vice President of Financial Planning and Analysis, Chief Financial Officer of the Airlines Business Unit, Director of Finance for the Transportation Systems Division, Investor Relations Manager and other senior finance positions. Prior to joining Honeywell, Mr. Trapp held several treasury and finance operational roles at United Business Media, Inc. and Pearson, Inc. Mr. Trapp holds a BS in Accounting from Providence College and an MBA in Finance from Northeastern University.

"I am very excited to join Abiomed, a company that has and continues to revolutionize patient care with its world class Impella technology," said Mr. Trapp. "I am committed to working closely with the employees and shareholders to further grow the company and continue Abiomed's tradition of strong execution."

"After an extensive search, we are pleased to welcome Todd Trapp to our executive team at Abiomed," said Michael R. Minogue, Chairman, President and Chief Executive Officer, Abiomed. "Todd's impressive proven record of accomplishment as a global CFO exemplifies his financial expertise, operational discipline and leadership. Todd will help Abiomed rise to the next level for the patients that we serve and our shareholders."

ABOUT IMPELLA HEART PUMPS

The Impella 2.5®, Impella CP®, Impella 5.0® and Impella LD® are FDA-approved heart pumps used to treat heart attack or cardiomyopathy patients in cardiogenic shock, and have the unique ability to enable native heart recovery, allowing patients to return home with their own heart. The Impella 2.5 and Impella CP devices are also approved to treat certain advanced heart failure patients undergoing elective and urgent percutaneous coronary interventions (PCI) such as stenting or balloon angioplasty, to re-open blocked coronary arteries. Abiomed's right-side heart pump, the Impella RP® device, is FDA approved to treat patients experiencing acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infarction, heart transplant, or open-heart surgery. To learn more about the Impella platform of heart pumps, including their approved indications and important safety and risk information associated with the use of the devices, please visit: www.protectedpci.com.

The ABIOMED logo, ABIOMED, Impella, Impella 2.5, Impella 5.0, Impella LD, Impella CP, Impella RP, and Recovering Hearts. Saving Lives. are registered trademarks of ABIOMED, Inc. in the U.S. and in certain foreign countries.

ABOUT ABIOMED 
Based in Danvers, Massachusetts, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. For additional information, please visit: www.abiomed.com.

FORWARD-LOOKING STATEMENTS

This release contains forward-looking statements, including statements regarding development of Abiomed's existing and new products, the Company's progress toward commercial growth, and future opportunities and expected regulatory approvals. The Company's actual results may differ materially from those anticipated in these forward-looking statements based upon a number of factors, including uncertainties associated with development, testing and related regulatory approvals, including the potential for future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological change, government regulation, litigation matters, future capital needs and uncertainty of additional financing, and other risks and challenges detailed in the Company's filings with the Securities and Exchange Commission, including the most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

For further information please contact: 
Ingrid Goldberg Ward
Director, Investor Relations
978-646-1590
igoldberg@abiomed.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Abiomed via Globenewswire

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Sanan IC Announces Commercial Release of 6-Inch SiC Wafer Foundry Process19.12.2018 15:00Pressemelding

SUNNYVALE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- SANAN INTEGRATED CIRCUIT CO., LTD. (Sanan IC), a pure-play wafer foundry with its advanced compound semiconductor technology platform, today announced that it has achieved full process qualification for commercial release of its 6-inch silicon carbide (SiC) technology to add to its foundry services portfolio. Committed to providing advanced materials manufacturing capability for serving the global market, the company now offers SiC technology which has emerged as the most mature wide bandgap (WBG) semiconductor intended for circuit designs in power electronics. With the ability to ensure its supply chain, the company provides a dedicated capacity for its 6-inch SiC wafer processing services on top of its III-V compound manufacturing, namely for gallium arsenide (GaAs), gallium nitride (GaN), and indium phosphide (InP). “We are delighted to expand our wafer foundry services to now include SiC and make it commercially available to the

Finland’s National Institute for Health and Welfare joins SNOMED International as the organization’s 36th Member.19.12.2018 15:00Pressemelding

London, United Kingdom, Dec. 19, 2018 (GLOBE NEWSWIRE) -- SNOMED International and the Finnish National Institute for Health and Welfare (THL) are pleased to announce that Finland has joined the organization as its thirty-sixth Member. Finland, one of the leading nations in the area of information and communication technology, has set the development of eHealth technologies as a high priority and has quickly become a pioneer in digital health. Its largest national digital healthcare project, the Kanta Service, i.e. the National Archive of Health Information, is one of the most comprehensive systems of its kind globally, covering already the entire Finnish public healthcare sector as well as most of the private sector. The development of Kanta Service began around 2005, and the first laws concerning the digital service were enacted in 2007. A prerequisite to this being the development of information systems and standards and particularly their usability. The Kanta Service is a collabora

Plug Power to Provide Business Update on January 9, 201919.12.2018 13:00Pressemelding

Company will review 2018 success and provide 2019 projections LATHAM, N.Y., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a leading provider of energy solutions that change the way the world moves, will hold its annual business update conference call on January 9, 2019. On this call, the Company will review successes during 2018 with customers in its GenKey, GenDrive, GenSure and ProGen product lines. Additionally, Plug Power management will provide projections expected for 2019. Save the Date: Date: January 9, 2019 Time: 10:00 am ET “2018 has been an important year, not just for Plug Power, but for the industry it leads with recording-holding metrics, including 23,000 fuel cell units deployed in the material handling market, 200 million hours of product runtime, and 16 million hydrogen fills enabled,” said Andy Marsh, CEO of Plug Power. “Plug Power has accomplished what no other hydrogen fuel cell company in the world has been able to. Of utmost importance, the Plu

Open Compute Project Announces Future Technologies Symposium19.12.2018 09:00Pressemelding

Event focused on future technology innovation to be held at the annual 2019 OCP Global Summit. San Jose, CA, Dec. 19, 2018 (GLOBE NEWSWIRE) -- For immediate release. The Open Compute Project Foundation (OCP) invites students and researchers from around the world to submit posters for the 2019 OCP Future Technologies Symposium, as a new addition to the OCP Global Summit in San Jose, CA, USA. Innovations that illustrate efficiency, scalability and scale using open source principles for scalable computing in compute, storage, networking or any OCP project; as well as those which are multi-disciplinary and cover leading technology solutions, such as edge computing. Draft papers will be reviewed by the OCP leadership, the Incubation Committee Co-Chairs and Project Leaders. Acceptance will be based on content and overall program balance. The authors of the accepted drafts will have the opportunity to submit a poster and present their work during the OCP Global Summit in San Jose, CA on March

Open Compute Project Announces Future Technologies Symposium19.12.2018 09:00Pressemelding

Event focused on future technology innovation to be held at the annual 2019 OCP Global Summit. San Jose, CA, Dec. 19, 2018 (GLOBE NEWSWIRE) -- For immediate release. The Open Compute Project Foundation (OCP) invites students and researchers from around the world to submit posters for the 2019 OCP Future Technologies Symposium, as a new addition to the OCP Global Summit in San Jose, CA, USA. Innovations that illustrate efficiency, scalability and scale using open source principles for scalable computing in compute, storage, networking or any OCP project; as well as those which are multi-disciplinary and cover leading technology solutions, such as edge computing. Draft papers will be reviewed by the OCP leadership, the Incubation Committee Co-Chairs and Project Leaders. Acceptance will be based on content and overall program balance. The authors of the accepted drafts will have the opportunity to submit a poster and present their work during the OCP Global Summit in San Jose, CA on March

LeddarTech and Cailabs Sign Collaboration Agreement on Combining LiDAR and Laser Beam Shaping Solutions for the Automotive Market19.12.2018 06:05Pressemelding

RENNES, France and QUEBEC CITY, Dec. 19, 2018 (GLOBE NEWSWIRE) -- LeddarTech, an industry leader providing the most versatile and scalable automotive LiDAR development platform, announces that it has entered an agreement with Cailabs, a French deep tech company and global leader in light shaping technology, to explore combining LeddarTech’s solid-state LiDAR technology with Cailabs’ laser beam shaping solutions for the automotive industry. A memorandum of understanding between the two parties was signed on December 13, 2018. LeddarTech delivers a proprietary auto and mobility LiDAR platform based on the LeddarEngine™ (SoC + software) enabling high-performance, low-cost LiDAR sensor solutions and that is used by large Tier-1 suppliers to develop specific LiDARs for ADAS and autonomous driving applications. Cailabs develops and produces a unique range of optical components based on its know-how and its patented technological innovations, in particular, Multi-Plane Light Conversion (MPLC)